Belite Bio's $350 Million Public Offering: A Strategic Leap Forward

San Diego, Tuesday, 2 December 2025.
Belite Bio, a San Diego-based biotech firm, launches a $350 million public offering to advance its innovative therapies and operational growth, underscoring its commitment to unmet medical needs.